PBYI
#2959
Puma Biotechnology Inc - Common Stock
9.0 7 USD
-0.02%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-1.84%
Variación mensual
+13.94%
Variación en los últimos 6 meses
+64.61%
Cambio anual
+80.32%
Cierres anteriores
9.2 4
Open
9.0 8
Mínimo
9.0 5
Máximo
9.1 2
Volumen
145
Financials
- Market Capitalization 468.19 M
- Employee 179
- Founded 2007
- CEO N/A
- Website www.pumabiotechnology.com
- Headquarter Delaware, United States
- FIGI BBG0018YXYX7
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
9.75
Relación precio/flujo de caja
1.32
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2947 |  CCCC C4 Therapeutics, Inc. - Common Stock | 3.85 USD | -6.10% | -3.75% | +11.59% | +52.17% | 473.65 M USD | ||
| 2950 |  PRTA Prothena Corporation plc - Ordinary Shares | 9.34 USD | +2.75% | -1.16% | +8.10% | +12.94% | 479.49 M USD | ||
| 2964 |  RLMD Relmada Therapeutics, Inc. - Common Stock | 4.34 USD | -3.98% | -6.26% | -17.02% | +422.89% | 462.95 M USD | ||
| 2979 |  PRLD Prelude Therapeutics Incorporated - Common Stock | 5.47 USD | -13.72% | -17.50% | +17.89% | +324.03% | 436.53 M USD |